Rollins (NYSE:ROL) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $714.00 million which beat the analyst consensus estimate of $686.33 million by 4.03 percent. This is a 11.88 percent increase over sales of $638.20 million the same period last year.
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
(Part three of a four-part series)
Despite ongoing legal setbacks, psychedelics research has reemerged and it is proving that psilocybin reduces brain connections within the usual networks while amplifying links between less connected areas.
